publication venue for Drugging DNA repair to target T-ALL cells.. 59:1746-1749. 2018 Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials.. 59:1624-1633. 2018 Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide.. :1-9. 2016 Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis.. 54:1762-1768. 2013 Telomere length in myelodysplastic syndromes.. 52:1528-1536. 2011 Spontaneous regression of high grade primary gastric Lymphoma in an untreated viral hepatitis infection. 2014
